Buys
Open market- Shares
- Avg price
- Total value
Craig C. Hopkinson - EVP R&D, Chief Medical Officer at Alkermes plc.
Issuer-level insider activity
- Role
- EVP R&D, Chief Medical Officer
- Issuer ticker
- ALKS on Nasdaq
- Entity type
- Individual
- Source filing history
- Open source filing history
Identity
Names, identifiers, and filing context for this profile.
1 identity field
Source evidence
Original filing metadata and source links for verification.
1 source field
Past-year transaction volume for Craig C. Hopkinson in Alkermes plc.
Sells
Open market- Shares
- -97,748
- Avg price
- $35.99
- Total value
- -$3,517,788
Net
Past year- Shares
- -97,748
- Share %
- -100%
- Total value
- -$3,517,788
Reported holdings for Craig C. Hopkinson in Alkermes plc.
Form 4 holding
EVP R&D, Chief Medical Officer
Alkermes plc.
- Security class
- Ordinary Shares
- Shares / value
- 69,389
- Estimated value
- $3,370,917
- Report date
- 03 Aug 2026
- Price
- $48.58
- Ownership
- Direct
Form 4 holding
EVP R&D, Chief Medical Officer
Alkermes plc.
- Security class
- Employee Stock Option (Right to Buy)
- Shares / value
- 66,276
- Estimated value
- Report date
- 03 Aug 2026
- Price
- Ownership
- Direct
- Underlying class
- Ordinary Shares
- Underlying amount
Form 4 holding
EVP R&D, Chief Medical Officer
Alkermes plc.
- Security class
- Restricted Stock Unit Award
- Shares / value
- 38,568
- Estimated value
- Report date
- 02 Mar 2026
- Price
- Ownership
- Direct
- Underlying class
- Ordinary Shares
- Underlying amount
Transaction history for Craig C. Hopkinson in Alkermes plc.
| Sym | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|
* marks a reported price that did not pass the local price check.